Bain Capital Life Sciences Investors’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.95M | Hold |
|
|||||
|
2025
Q1 | $7.43M | Hold |
|
|||||
|
2024
Q4 | $8.33M | Hold |
|
|||||
|
2024
Q3 | $8.33M | Hold |
|
|||||
|
2024
Q2 | $8.23M | Hold |
|
|||||
|
2024
Q1 | $10M | Hold |
|
|||||
|
2023
Q4 | $7.58M | Hold |
|
|||||
|
2023
Q3 | $7.46M | Hold |
|
|||||
|
2023
Q2 | $9.3M | Hold |
|
|||||
|
2023
Q1 | $8.33M | Hold |
|
|||||
|
2022
Q4 | $12M | Hold |
|
|||||
|
2022
Q3 | $14.1M | Hold |
|
|||||
|
2022
Q2 | $17.6M | Hold |
|
|||||
|
2022
Q1 | $17.9M | Hold |
|
|||||
|
2021
Q4 | $22.2M | Sell |
|
|||||
|
2021
Q3 | $130M | Sell |
|
|||||
|
2021
Q2 | $121M | Hold |
|
|||||
|
2021
Q1 | $347M | Hold |
|
|||||
|
2020
Q4 | $235M | Buy |
|